CYP17-and CYP11B-dependent steroid hydroxylases as drug development targets

T Hakki, R Bernhardt - Pharmacology & therapeutics, 2006 - Elsevier
Steroid hormone biosynthesis is catalyzed by the action of a series of cytochrome P450
enzymes as well as reductases. Defects in steroid hydroxylating P450s are the cause of …

CYP17-and CYP11B-dependent steroid hydroxylases as drug development targets

T Hakki, R Bernhardt - Pharmacology & therapeutics, 2006 - pubmed.ncbi.nlm.nih.gov
Steroid hormone biosynthesis is catalyzed by the action of a series of cytochrome P450
enzymes as well as reductases. Defects in steroid hydroxylating P450s are the cause of …

CYP17-and CYP11B-dependent steroid hydroxylases as drug development targets.

T Hakki, R Bernhardt - Pharmacology & Therapeutics, 2006 - europepmc.org
Steroid hormone biosynthesis is catalyzed by the action of a series of cytochrome P450
enzymes as well as reductases. Defects in steroid hydroxylating P450s are the cause of …

[引用][C] CYP17-and CYP11B-dependent steroid hydroxylases as drug development targets

T Hakki, R Bernhardt - Pharmacology & Therapeutics, 2006 - cir.nii.ac.jp
CYP17- and CYP11B-dependent steroid hydroxylases as drug development targets | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

CYP17-and CYP11B-dependent steroid hydroxylases as drug development targets

T Hakki, R Bernhardt - Pharmacology and Therapeutics, 2006 - infona.pl
Steroid hormone biosynthesis is catalyzed by the action of a series of cytochrome P450
enzymes as well as reductases. Defects in steroid hydroxylating P450s are the cause of …

[引用][C] CYP17-and CYP11B-dependent steroid hydroxylases as drug development targets

T HAKKI - Pharmacol. Ther., 2006 - cir.nii.ac.jp

[引用][C] CYP17-and CYP11B-dependent steroid hydroxylases as dmg development targets

T HAKKI, R BERNHARDT - Pharmacology & therapeutics, 2006 - Elsevier